Gene Therapy for Respiratory Diseases: Progress and a Changing Context.
作者信息
Alton Eric W F W, Boyd A Christopher, Davies Jane C, Gill Deborah R, Griesenbach Uta, Harman Tracy E, Hyde Stephen, McLachlan Gerry
机构信息
Gene Therapy Group, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
UK CF Gene Therapy Consortium, London, United Kingdom.
出版信息
Hum Gene Ther. 2020 Sep;31(17-18):911-916. doi: 10.1089/hum.2020.142.
Abstract
摘要
相似文献
1
Gene Therapy for Respiratory Diseases: Progress and a Changing Context.呼吸系统疾病的基因治疗：进展与不断变化的背景
Hum Gene Ther. 2020 Sep;31(17-18):911-916. doi: 10.1089/hum.2020.142.
2
Laying the Foundation for Cystic Fibrosis Therapy: An Interview with Michael Boyle.为囊性纤维化治疗奠定基础：对迈克尔·博伊尔的采访
Hum Gene Ther. 2020 Sep;31(17-18):917-920. doi: 10.1089/hum.2020.29134.int. Epub 2020 Sep 11.
3
Breathing Easier: Molecular Therapeutics for Cystic Fibrosis.呼吸更轻松：囊性纤维化的分子疗法
Hum Gene Ther. 2020 Sep;31(17-18):905-906. doi: 10.1089/hum.2020.29135.mli.
4
New Directions in Pulmonary Gene Therapy.肺部基因治疗的新方向。
Hum Gene Ther. 2020 Sep;31(17-18):921-939. doi: 10.1089/hum.2020.166.
5
Cystic fibrosis: a look into the future of prenatal screening and therapy.囊性纤维化：产前筛查与治疗的未来展望
Birth Defects Res C Embryo Today. 2015 Mar;105(1):73-80. doi: 10.1002/bdrc.21091.
6
Adeno-associated virus vectors for gene therapy of cystic fibrosis.用于囊性纤维化基因治疗的腺相关病毒载体。
Methods Enzymol. 1998;292:717-32. doi: 10.1016/s0076-6879(98)92055-9.
7
[Cystic fibrosis and gene therapy].[囊性纤维化与基因治疗]
Nihon Rinsho. 2005 Dec;63 Suppl 12:607-16.
8
Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.基因治疗囊性纤维化为腺相关病毒在基因治疗中的应用铺平了道路。
Hum Gene Ther. 2020 May;31(9-10):538-541. doi: 10.1089/hum.2020.046.
9
Development of adeno-associated virus vectors for gene therapy of cystic fibrosis.用于囊性纤维化基因治疗的腺相关病毒载体的研发。
Curr Top Microbiol Immunol. 1996;218:119-44. doi: 10.1007/978-3-642-80207-2_8.
10
Novel Lung Tropic Adeno-Associated Virus Capsids for Therapeutic Gene Delivery.用于治疗性基因递送的新型肺靶向腺相关病毒衣壳
Hum Gene Ther. 2020 Sep;31(17-18):996-1009. doi: 10.1089/hum.2020.169. Epub 2020 Sep 8.
引用本文的文献
1
Mechanism-Based Neuromodulation in Augmenting Respiratory Motor Function in Individuals with Spinal Cord Injury.基于机制的神经调节增强脊髓损伤个体的呼吸运动功能
J Clin Med. 2025 May 29;14(11):3827. doi: 10.3390/jcm14113827.
2
Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human Trial.用于囊性纤维化的慢病毒基因疗法：一种有前景的方法及首次人体试验。
Am J Respir Crit Care Med. 2024 Dec 15;210(12):1398-1408. doi: 10.1164/rccm.202402-0389CI.
3
Aerosol-Mediated Non-Viral Lung Gene Therapy: The Potential of Aminoglycoside-Based Cationic Liposomes.气溶胶介导的非病毒肺部基因治疗：基于氨基糖苷的阳离子脂质体的潜力
Pharmaceutics. 2021 Dec 23;14(1):25. doi: 10.3390/pharmaceutics14010025.
本文引用的文献
1
Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders' consensus view.CFTR 调节剂相关的实质性临床获益时代的囊性纤维化药物试验设计：利益相关者的共识观点。
J Cyst Fibros. 2020 Sep;19(5):688-695. doi: 10.1016/j.jcf.2020.05.012. Epub 2020 Jun 8.
2
Chimeric antigen receptor T cell therapy comes to clinical practice.嵌合抗原受体 T 细胞疗法走向临床实践。
Curr Oncol. 2020 Apr;27(Suppl 2):S115-S123. doi: 10.3747/co.27.5283. Epub 2020 Apr 1.
3
Development of Large-Scale Downstream Processing for Lentiviral Vectors.慢病毒载体大规模下游处理技术的发展
Mol Ther Methods Clin Dev. 2020 Mar 30;17:717-730. doi: 10.1016/j.omtm.2020.03.025. eCollection 2020 Jun 12.
4
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease.CFTR 调节剂治疗对严重肺囊性纤维化患者结局的影响。
Eur Respir Rev. 2020 Mar 20;29(155). doi: 10.1183/16000617.0112-2019. Print 2020 Mar 31.
5
Immune Responses to Viral Gene Therapy Vectors.病毒基因治疗载体的免疫反应。
Mol Ther. 2020 Mar 4;28(3):709-722. doi: 10.1016/j.ymthe.2020.01.001. Epub 2020 Jan 10.
6
Gene therapy for severe combined immunodeficiencies and beyond.基因治疗重度联合免疫缺陷病及其他疾病。
J Exp Med. 2020 Jan 6;217(2). doi: 10.1084/jem.20190607.
7
Integrating the multiple breath washout test into international multicentre trials.将多次呼吸冲洗试验纳入国际多中心试验。
J Cyst Fibros. 2020 Jul;19(4):602-607. doi: 10.1016/j.jcf.2019.11.006. Epub 2019 Nov 24.
8
Insights into the variability of nasal potential difference, a biomarker of CFTR activity.鼻腔电位差变化的洞察，CFTR 活性的生物标志物。
J Cyst Fibros. 2020 Jul;19(4):620-626. doi: 10.1016/j.jcf.2019.09.015. Epub 2019 Nov 4.
9
Treating the Underlying Cystic Fibrosis Transmembrane Conductance Regulator Defect in Patients with Cystic Fibrosis.治疗囊性纤维化跨膜电导调节因子缺陷型囊性纤维化患者。
Semin Respir Crit Care Med. 2019 Dec;40(6):762-774. doi: 10.1055/s-0039-1696664. Epub 2019 Oct 28.
10
Cell-based therapy for idiopathic pulmonary fibrosis.基于细胞的特发性肺纤维化治疗方法。
Stem Cell Investig. 2019 Aug 16;6:22. doi: 10.21037/sci.2019.06.09. eCollection 2019.
Zotero 插件